Methylene Blue, LDN, and Compounding Options for Inflammation
Compounding Innovations
•
49m
49 Min
Handout: https://bit.ly/4gWUFUz
During this presentation, Sara Hover, RPh, will discuss Methylene Blue, LDN, and compounding options for inflammation. After watching this presentation, the viewer should be able to:
•Examine the most recent methylene blue literature.
•Understand the role of low-dose naltrexone in depression and memory.
•Analyze the connection between the gut microbiota and mitochondria.
•Identify compounding options for chronic conditions.
Up Next in Compounding Innovations
-
Mebendazole & Ivermectin in Oncology
Download Handouts: https://bit.ly/4jkDKwj
We invite you to watch our FREE webinar to discover how the well-known antiparasitics, mebendazole and ivermectin, are being researched as potential options in cancer therapy.
What you’ll gain by attending:
• Expert insights into the mechanisms of acti... -
What's Hot In Compounding (2025)
52 min
Handout: https://bit.ly/4vEmt92
During this presentation, Sebastian Denison, RPh will discuss what's hot in compounding. After this presentation the viewer should be able to recall current information about methylene blue, LDM, ketamine, antibiotics, metformin, mebendazole, ivermectin,...
